Is NRIX or NRXP more undervalued in 2026?

CirclFi compares Nurix Therapeutics, Inc. (NRIX) and NRX Pharmaceuticals, Inc. (NRXP) using 13 institutional-grade valuation models. NRIX has a Quality of Company score of 6.4/10 while NRXP scores 3.9/10.

Which is a better buy — NRIX or NRXP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NRIX and NRXP valuations compare?

NRIX at $17.67 and NRXP at $4.44 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NRIX vs NRXP Valuation Comparison 2026 — Intrinsic Value Analysis

NRIX

Biotechnology

Nurix Therapeutics, Inc.

Quality

6.4

out of 10

Value Trap

SAFE

Price

$17.67

Last close

Models

9/13

Active

NRXP

Biotechnology

NRX Pharmaceuticals, Inc.

Quality

3.9

out of 10

Value Trap

LOW

Price

$4.44

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	NRIX Fair Value	NRIX Upside	NRXP Fair Value	NRXP Upside
Bayesian DCF	Intrinsic	$4.91	-72.2%	$1.26	-71.6%
Earnings Power Value	Intrinsic	—	—	$0.34	-89.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$4.75	-73.1%	—	—
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NRIX vs NRXP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NRIX vs NRXP — Which Stock Is More Undervalued?

NRIX scores higher with a 6.4/10 quality rating vs NRXP's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Nurix Therapeutics, Inc. (NRIX) and NRX Pharmaceuticals, Inc. (NRXP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NRIX currently trades at $17.67 with a QOC of 6.4/10, while NRXP trades at $4.44 with a QOC of 3.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).